Page - (000406) - in Biomedical Chemistry: Current Trends and Developments

approaches to overcome cancer drug resistance. Advanced Drug Delivery Reviews, 65(13-14), 1866-1879. Marrack, P., McKee, A. S., Munks, M. W. (2009). Towards an understanding of the adjuvant action of aluminium. Nature Reviews Immunology, 9(4), 287-293. Maruyama, K. (2011). Intracellular targeting delivery of liposomal drugs to solid tumors based on epr effects. Advanced Drug Delivery Reviews, 63(3), 161-169. Matsumura, Y., Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Research, 46(12 Pt 1), 6387-6392. Mayer, L. D., Harasym, T. O., Tardi, P. G., et al. (2006). Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. Molecular Cancer Therapeutics, 5(7), 1854-1863. Melancon, M. P., Lu, W., Zhong, M., et al. (2011). Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer. Biomaterials, 32(30), 7600-7608. Meng, H., Xue, M., Xia, T., et al. (2010). Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by ph-sensitive nanovalves. Journal of the American Chemical Society, 132(36), 12690-12697. Miele, E., Spinelli, G. P., Miele, E., et al. (2012). Nanoparticle-based delivery of small interfering rna: Challenges for cancer therapy. International Journal of Nanomedicine, 7, 3637-3657. Misra, R., Acharya, S., Sahoo, S. K. (2010). Cancer nanotechnology: Application of nanotechnology in cancer therapy. Drug Discovery Today, 15(19-20), 842-850. Mody, H. R. (2011). Cancer nanotechnology: Recent trends and developments. Internet Journal of Medical Update - EJOURNAL, 6(1). Moghimi, S. M., Hunter, A. C., Murray, J. C. (2005). Nanomedicine: Current status and future prospects. FASEB J, 19(3), 311-330. Monjanel, H., Deville, L., Ram-Wolff, C., et al. (2014). Brentuximab vedotin in heavily treated hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients. British Journal of Haematology, 166(2), 306-308. Monjazeb, A. M., Hsiao, H. H., Sckisel, G. D., et al. (2012). The role of antigen-specific and non- specific immunotherapy in the treatment of cancer. Journal of Immunotoxicology, 9(3), 248- 258. Moon, J. J., Suh, H., Li, A. V., et al. (2012). Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand tfh cells and promote germinal center induction. Proceedings of the National Academy of Sciences, 109(4), 1080-1085. Nakayama, M., Akimoto, J., Okano, T. (2014). Polymeric micelles with stimuli-triggering systems for advanced cancer drug targeting. Journal of Drug Targeting, 22(7), 584-599. Nandakumar, K. S., Shakya, A. K. (2012). Polymers as immunological adjuvants: An update on recent developments. Journal of Bioscience and Biotechnology, 1(3), 199-210. Nandedkar, T. D. (2009). Nanovaccines: Recent developments in vaccination. Journal of Bioscience, 34(6), 995-1003. Ndungu, F. M., Olotu, A., Mwacharo, J., et al. (2012). Memory b cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proceedings of the National Academy of Sciences, 109(21), 8247-8252.